from Global Health Program

Health-care Provision and Health-care Reform in Post-Mao China

April 3, 2014

Testimony
Testimony by CFR fellows and experts before Congress.

More on:

China

Health

An effective strategy to engage China's health-care sector requires the U.S. government to continue promoting business opportunities for U.S. biopharmaceutical firms, hospital groups, and insurance companies, CFR Senior Fellow for Global Health Yanzhong Huang tells the U.S.-China Economic and Security Review Commission. In the meantime, it is also important for the U.S. government and companies to demonstrate the willingness to work with China in addressing health issues of their immediate concern.

More on:

China

Health

Top Stories on CFR

Election 2024

The European Union (EU) began implementing the Digital Services Act (DSA) this year, just in time to combat online disinformation and other electoral interference in the dozens of elections taking pl…

Taiwan

In his inaugural address, Taiwan’s new president Lai Ching-te signaled broad continuity on cross-strait issues. China, however, is likely to respond with increased pressure. 

Kenya

During Kenya’s state visit, the United States should work toward building a more resilient model of U.S.-Africa partnerships.